Drug profile · INN
phentermine hydrochloride
PHENTERMINE HYDROCHLORIDE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
phentermine hydrochloride (PHENTERMINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12208148
Dental restorative curable composition
granted -
US 12201658
Viral gene therapy as treatment for cholesterol storage disease or disorder
granted -
US 12150445
Method and composition for hypothermic storage of placental tissue
granted -
US 12128036
Compositions and methods for storage stable ophthalmic drugs
granted -
US 12060558
Methods and compositions for treatment of cholesteryl ester storage disease
granted -
US 11219643
Compositions for cellular restoration and methods of making and using same
granted -
US 11185554
Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease
granted -
US 11083708
Pharmacological restoration of epithelial or endothelial barrier integrity by agents blocking EPAC/RAP1 signaling
granted
Frequently asked questions
What is phentermine hydrochloride?
phentermine hydrochloride (PHENTERMINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for phentermine hydrochloride?
PHENTERMINE HYDROCHLORIDE is a marketed brand name for phentermine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of phentermine hydrochloride?
phentermine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.